Expression and Yes-Associated Protein in Gastric Adenocarcinoma and Inhibitory Effects of its Knockdown on Gastric Cancer Cell Proliferation and Metastasis

Abstract

Yes-associated protein (YAP) has been implicated as an oncogene in multiple human cancers. In the present study, human gastric adenocarcinoma tissues of different grades (N=78) were collected and the mRNA and protein expression of YAP and phosphorylated YAP (p-YAP) in gastric adenocarcinomas were evaluated using immunohistochemistry, Real-time PCR and Western blot assays. Then, human gastric cancer SGC-7901 cells were stably transfected with lentivirus-mediated YAP small hairpin RNA (shRNA). The expression levels of YAP, proliferating cell nuclear antigen (PCNA) and metalloproteinase-2 (MMP-2) were detected and the effects of shRNA-mediated knockdown of YAP on cell proliferation and metastasis were assessed in gastric cancer cells. As a result, the expression of YAP was observed in 69.23% gastric adenocarcinoma tissues, elevating with the ascending order of tumor malignancy. Knockdown of YAP could down-regulated the expression of PCNA and MMP-2, and inhibit the proliferation and metastasis of gastric cancer cells. In conclusion, YAP is strongly expressed in gastric adenocarcinomas, and knockdown of YAP may inhibit gastric cancer cell proliferation and metastasis through down-regulation of PCNA and MMP-2 expression, suggesting that YAP represents an important therapeutic target in human gastric cancer.

Keywords

Yes-associated protein small hairpin RNA gastric cancer proliferation metastasis

References

Jemal

Bray

Center

Ferlay

Ward

Forman

. Global cancer statistics. CA Cancer J Clin 2011; 61:69–90.

Tajima

Yamazaki

Makino

. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: Clinicopathologic significance and genetic background. Clin Cancer Res 2006; 12:6469–79.

Irvine

. Yorkie: The final destination of Hippo signaling. Trends Cell Biol 2010; 20:410–7.

Zhao

Wei

. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21:2747–61.

Zender

Spector

Xue

. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006; 125:1253–67.

Overholtzer

Zhang

Smolen

. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 2006; 103:12405–10.

Guo

Kleeff

Zhao

. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma. Int J Mol Med 2006; 17:761–7.

Steinhardt

Gayyed

Klein

. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008; 39:1582–9.

Yao

Lee

. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009; 115:4576–85.

10.

Orr

Bai

Odia

. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J Neuropathol Exp Neurol 2011; 70:568–77.

11.

Muramatsu

Imoto

Matsui

. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 2011; 32:389–98.

12.

Hanahan

Weinberg

: The hallmarks of cancer: The next generation. Cell 2011; 144:646–74.

13.

Xin

Zhao

Luo

. Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions. World J Gastroenterol 2009; 15:4055–61.

14.

Lam-Himlin

Daniels

Gayyed

. The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: A novel oncogenic pathway. Int J Gastrointest Cancer 2006; 37:103–9.

15.

Yuan

Tomlinson

Lara

. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 2008; 15:1752–9.

16.

Zagurovskaya

Shareef

Das

. EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells. Oncogene 2009; 28:1121–31.

17.

Kang

Tong

Chan

. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res 2011; 17:2130–9.

18.

Tomlinson

Gudmundsdottir

Luong

. JNK. phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis 2010; l:e29.

19.

Zhang

Pan

. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma. Oral Oncol 2011; 47:693–7.

20.

Wang

Dong

Zhang

. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 2010; 101:1279–85.

21.

Liu

Chen

Poon

Luk

. Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin Ther Targets 2010; 14:855–68.

22.

Zhou

Zhu

. RNA Interference mediated YAP gene silencing inhibits invasion and metastasis of human gastric cancer cell line SGC-7901. Hepatogastroenterology 2011; 58:2156–61.

23.

Czyzewska

Guzińska-Ustymowicz

Lebelt

. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers. Rocz Akad Med Bialymst 2004; 49:64–6.

24.

Cawston

Wilson

. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 2006; 20:983–1002.

25.

Zhou

Zhu

Zhang

. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line. Mol Med Report 2011; 4:1075–82.